SOAR Act of 2025
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Overview
The Supplemental Oxygen Access Reform Act of 2025 (SOAR Act) aims to improve access to and payment for supplemental oxygen therapy under Medicare. It proposes separate, inflation-indexed payments for oxygen and related equipment, supplies, and services, moving them out of the competitive acquisition program. The bill also establishes requirements for electronic prescriptions, protects respiratory therapist services, and implements measures to ensure beneficiary rights and program integrity through standardized templates and clear communication.
Key provisions
- Separate, inflation-indexed payments for oxygen and related equipment, supplies, and services under Medicare.
- Exclusion of oxygen and related equipment, supplies, and services from the competitive acquisition program.
- Establishment of a non-budget neutral add-on payment for respiratory therapist services.
- Implementation of electronic templates for prescribing oxygen and related equipment, supplies, and services.
- Requirements for beneficiary notice regarding cost-sharing obligations and supplier information.
- Establishment of clinical criteria for coverage of liquid oxygen.
- Creation of a monthly notice for beneficiaries receiving supplemental oxygen regarding the end of cost-sharing obligations.
- Enhanced protections for beneficiaries receiving oxygen, including the right to choose suppliers and receive clear communication.
Who is affected
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
9 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours